Associate Mizuho vs Senior Analyst Mid-Cap JPM

Hi there,

I'm currently an AN2 in Leverage Finance at HSBC and I have these 2 options open and was looking for some advice. 


Option 1:
AN2 in Mid-Cap Coverage at JPM

Option 2:
AS1 in Consumer and Healthcare Coverage at Mizuho



From a coverage team/work perspective, I don't have too much of a preference, as they're both covering debt, equity, and M&A deals. I'm keener on long-term prospects and exit-ops. 

JPM would be a slight hit in salary in the short-term, but it seems like the team is doing a lot of middle-market financial sponsor coverage, which might be interesting.

Does anyone have any interesting perspectives on the pros/cons of each option?

 

10 Comments
 

Based on the most helpful WSO content, here are some insights to consider for your decision:

Option 1: AN2 in Mid-Cap Coverage at JPM

  • Pros:

    • Brand Name & Prestige: JPMorgan's brand carries significant weight, especially for long-term career prospects and exit opportunities. Even in a mid-cap coverage role, the JPM name can open doors to top-tier buyside roles or lateral moves.
    • Middle-Market Financial Sponsor Coverage: This could provide valuable exposure to private equity sponsors, which is highly relevant if you're considering a buyside exit in the future.
    • Mobility: JPMorgan offers strong internal mobility options, allowing you to potentially transition to other groups or regions within the firm.
    • Optionality: The skills and network you build at JPM can provide considerable optionality for future roles, whether in banking or beyond.
  • Cons:

    • Short-Term Salary Hit: As you mentioned, there’s a slight reduction in compensation compared to your current role or the Mizuho offer.
    • Mid-Cap Focus: While mid-cap deals can be interesting, they may not carry the same prestige or scale as large-cap transactions, which could be a factor depending on your long-term goals.

Option 2: AS1 in Consumer and Healthcare Coverage at Mizuho

  • Pros:

    • Promotion to Associate: Moving up to AS1 is a significant milestone, and it positions you for more responsibility and leadership opportunities within the team.
    • Sector Focus: Consumer and healthcare are robust sectors with consistent deal flow, which could provide strong experience across various products (debt, equity, M&A).
    • Compensation: The AS1 role likely comes with a higher salary and bonus compared to the AN2 role at JPM, which could be appealing in the short term.
  • Cons:

    • Brand Perception: While Mizuho is a reputable firm, it doesn’t carry the same global prestige as JPMorgan, which could impact long-term exit opportunities.
    • Exit Opportunities: Mizuho’s platform may not offer the same level of exposure to top-tier buyside roles or lateral opportunities as JPMorgan.

Key Considerations:

  1. Long-Term Goals: If your focus is on maximizing exit opportunities and building a strong brand on your resume, JPMorgan might be the better choice. The prestige and network associated with JPM can be a significant advantage.
  2. Short-Term vs. Long-Term Trade-Offs: Mizuho offers a higher title and compensation in the short term, but JPMorgan may provide better long-term career mobility and optionality.
  3. Sector and Deal Focus: Consider which team’s deal flow and sector focus align more closely with your interests and future aspirations.

Ultimately, if long-term prospects and exit opportunities are your priority, the JPMorgan role may be the stronger option despite the short-term salary hit. However, if immediate compensation and a step up in title are more important to you, Mizuho could be the better fit.

Sources: M&A Pros and Cons, CIB Credit Risk J.P. Morgan, A Tale of 3 Offers: What should I consider?, Am I missing something about buyside exits?, Q&A: ex-bank trader now running crypto hedge fund. questions?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 
Most Helpful

It depends on your long-term ambitions. Are you ambitious and want to take a swing at top echelon outcomes? Then JPM will probably get you there in the long run if you can survive, even if taking a short hit in comp and title right now. Also better exit options into corporate/other parts of finance as it’s one of the strongest brands around. Do you want to maximize short-term comp and happy with a more middle of the finance road outcome down the line? Mizuho.

Finance is an endurance game. It’s about optimizing for endurance at the highest possible level that is long-term sustainable for you. Crashing out of finance due to burn out after 2yrs of JPM is less preferable than crushing 10yrs at Mizuho.

 

Currently at JPM. Mid cap is a sweat shop, yes the people are nice and the deals are cool, but be prepared to bust your ass. I’m talking 3:30am is a normal log off time for this team.

 

Yeah I'm pretty certain it's in Corporate Banking in London. In the US they have an investment banking Mid-Cap team, but in London it's Corporate. If you look for anyone doing Mid-Cap in London, they are usually very vague. They things like 'corporate and investment banking', or won't refer to themselves as an investment banking analyst. You're M&A 'adjacent' I guess..

 

Are you in LAF or LevFin Coverage - this matters as you need to think about longer term storyline. 

If LevFin Coverage, JPM makes more sense as its also MM focused and you'll then exit to a top MM investing seat. 

If in LAF, joining Mizuho makes a lot more sense as from there, you could move again to a top coverage team or directly to MF investing seat.

 

Tenetur necessitatibus repellendus est quia cumque. Veniam perferendis praesentium dolor error impedit ad saepe. Laborum et ratione impedit odio quasi. Sit rem tempore quis perspiciatis totam nisi explicabo.

Ab inventore id eum est qui a. Eligendi perferendis aliquam facere suscipit repudiandae numquam. Inventore voluptatem et ipsam dolores sed quis iure et. Consequatur optio nihil saepe qui voluptas autem asperiores rerum. Omnis sunt id velit nisi beatae neque molestiae. Voluptatem debitis ab nemo at voluptate reprehenderit rerum occaecati. Ut culpa doloremque eaque quia veniam pariatur ab.

Ipsam neque molestiae doloremque temporibus mollitia nihil rerum. Repellendus ut autem tempora eos sit vero earum. Ducimus neque dolor doloremque quam quas aliquam autem. Velit et ut quia consequatur quam sequi. Molestiae sed id facilis dolorem consequatur.

Magnam ut debitis sunt. Incidunt repudiandae maiores sint. Rerum voluptas et consectetur iste ea officiis. Accusantium repellendus voluptate dolor sunt.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (77) $151
  • Intern/Summer Analyst (71) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
dosk17's picture
dosk17
98.9
7
DrApeman's picture
DrApeman
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”